Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Non Operating Income: 2013-2017

Historic Non Operating Income for Soleno Therapeutics (SLNO) over the last 4 years, with Dec 2017 value amounting to -$650,000.

  • Soleno Therapeutics' Non Operating Income fell 257.96% to -$650,000 in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.3 million, marking a year-over-year decrease of 179.21%. This contributed to the annual value of $11.8 million for FY2024, which is 393.36% up from last year.
  • According to the latest figures from Q4 2017, Soleno Therapeutics' Non Operating Income is -$650,000, which was down 567.63% from $139,000 recorded in Q3 2017.
  • Soleno Therapeutics' 5-year Non Operating Income high stood at $4.9 million for Q2 2015, and its period low was -$9.2 million during Q1 2015.
  • In the last 3 years, Soleno Therapeutics' Non Operating Income had a median value of $33,500 in 2016 and averaged -$284,525.
  • Over the last 5 years, Soleno Therapeutics' Non Operating Income had its largest YoY gain of 431.43% in 2015, and its largest YoY loss of 115,212.50% in 2015.
  • Soleno Therapeutics' Non Operating Income (Quarterly) stood at -$104,965 in 2013, then crashed by 1,691.53% to -$1.9 million in 2014, then skyrocketed by 135.21% to $662,200 in 2015, then crashed by 37.86% to $411,497 in 2016, then slumped by 257.96% to -$650,000 in 2017.
  • Its Non Operating Income was -$650,000 in Q4 2017, compared to $139,000 in Q3 2017 and -$88,000 in Q2 2017.